The estimated Net Worth of John W. Kapples is at least $8.75 Million dollars as of 8 February 2019. Mr. Kapples owns over 16,313 units of Insulet stock worth over $6,580,486 and over the last 9 years he sold PODD stock worth over $0. In addition, he makes $2,169,350 as Senior Vice President, General Counsel, and Secretary at Insulet.
John has made over 1 trades of the Insulet stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 16,313 units of PODD stock worth $3,714,959 on 8 February 2019.
The largest trade he's ever made was exercising 16,313 units of Insulet stock on 8 February 2019 worth over $3,714,959. On average, John trades about 604 units every 0 days since 2016. As of 8 February 2019 he still owns at least 28,896 units of Insulet stock.
You can see the complete history of Mr. Kapples stock trades at the bottom of the page.
John W. Kapples serves as Senior Vice President, General Counsel, Secretary of the Company. Mr. Kapples has served as our Senior Vice President, General Counsel and Secretary since March 2019. From December 2015 to March 2019, he served as Vice President, General Counsel and Secretary at GCP Applied Technologies, Inc. From February 2015 to August 2015, Mr. Kapples served as Vice President at Medtronic plc, where he assisted with legal transition and integration matters related to Medtronic's acquisition of Covidien plc. From November 2006 to January 2015, prior to Medtronic’s acquisition of Covidien, Mr. Kapples served as Vice President and Corporate Secretary of Covidien. Prior to his role at Covidien, Mr. Kapples served in various roles of increasing responsibility at Raytheon Company, including Assistant General Counsel and Secretary, and he was a Corporate Associate at Sullivan & Worcester LLP. Mr. Kapples earned both his Bachelor of Arts in English and his Juris Doctor from Georgetown University.
As the Senior Vice President, General Counsel, and Secretary of Insulet, the total compensation of John Kapples at Insulet is $2,169,350. There are 4 executives at Insulet getting paid more, with Shacey Petrovic having the highest compensation of $5,883,980.
John Kapples is 60, he's been the Senior Vice President, General Counsel, and Secretary of Insulet since 2019. There are 5 older and 15 younger executives at Insulet. The oldest executive at Insulet Corporation is John Fallon, 72, who is the Independent Director.
John's mailing address filed with the SEC is C/O INSULET CORPORATION, 100 NAGOG PARK, ACTON, MA, 01720.
Over the last 18 years, insiders at Insulet have traded over $64,849,299 worth of Insulet stock and bought 175,262 units worth $7,280,516 . The most active insiders traders include Jonathan Silverstein, Elizabeth H Weatherman, and Samuel D Colella. On average, Insulet executives and independent directors trade stock every 19 days with the average trade being worth of $2,473,148. The most recent stock trade was executed by Timothy J Scannell on 10 September 2024, trading 5,000 units of PODD stock currently worth $1,129,200.
insulet corporation is an innovative medical device company based in billerica, massachusetts. it was founded in 2000 with the mission of improving the lives of people with diabetes. specifically, through its revolutionary omnipod insulin management system, insulet seeks to expand the use of insulin pump therapy. studies have demonstrated the advantages of insulin pump therapy over multiple daily insulin injections (mdi); these advantages include better glycemic control, fewer hypoglycemic events, reduced glycemic variability1 and improved quality of life2. despite these benefits, most people still choose mdi therapy largely due to the complexity, cost and inconvenience of conventional pump technology. the omnipod is a discreet and easy-to-use system that eliminates many of the issues associated with conventional pumps. improvements include omnipod's lack of tubing; automated, virtually pain-free insertion; and two straightforward parts that communicate wirelessly. by breaking down
Insulet executives and other stock owners filed with the SEC include: